Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05374252	Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients	unknown	Phase 3	102	Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER	1	May 16, 2022	clinicaltrials
NCT02369939	Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy(HYCAN)	unknown	Phase 3	118	University of Erlangen-Nürnberg Medical SchoolOTHER	1